Join to View Full Profile
1365 Clifton Rd NE4th floor, Room C4004Atlanta, GA 30322
Phone+1 404-251-5544
Fax+1 404-778-5520
Dr. Leal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2007 - 2009
University of Illinois College of Medicine at ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2006 - 2007
Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2003 - 2006
Federal University of Ceara Faculty of MedicineClass of 2001
Certifications & Licensure
GA State Medical License 2021 - 2027
WI State Medical License 2007 - 2023
IL State Medical License 2003 - 2017
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Start of enrollment: 2011 Jun 20
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
- Join now to see all
Publications & Presentations
PubMed
- Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer.Jordyn P Higgins, Jennifer W Carlisle, Nader H Moniri, Shruti Gupta, Eziafa I Oduah
Future Oncology. 2025-01-01 - 2 citationsConsolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, Frances Shepherd, Elio Adib
Journal of Thoracic Oncology. 2025-01-01 - 1 citationsIntra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981.Richa Sharma, Shagun Sharma, Pratik Shriwas, Labdhi Mehta, An H Vu
Iscience. 2024-11-15
Authored Content
- Stereotactic Ablative Radiotherapy Safe for Unresectable NSCLC with ILDApril 2024
Press Mentions
NovoCure Scoops FDA Approval on Wearable for Metastatic Cancer TreatmentOctober 17th, 2024- FDA Approves Tumor Treating Fields as Part of Combination Therapy for Advanced Lung CancerOctober 16th, 2024
- Wearable Tumor-Zapping Medical Device Wins FDA Approval for Lung CancerOctober 16th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
